Correlation Between Alvotech and Emergent Biosolutions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alvotech and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Emergent Biosolutions, you can compare the effects of market volatilities on Alvotech and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Emergent Biosolutions.

Diversification Opportunities for Alvotech and Emergent Biosolutions

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Alvotech and Emergent is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Alvotech i.e., Alvotech and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between Alvotech and Emergent Biosolutions

Given the investment horizon of 90 days Alvotech is expected to generate 0.58 times more return on investment than Emergent Biosolutions. However, Alvotech is 1.73 times less risky than Emergent Biosolutions. It trades about -0.18 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about -0.23 per unit of risk. If you would invest  1,302  in Alvotech on December 30, 2024 and sell it today you would lose (347.00) from holding Alvotech or give up 26.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Alvotech  vs.  Emergent Biosolutions

 Performance 
       Timeline  
Alvotech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Alvotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Emergent Biosolutions 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Alvotech and Emergent Biosolutions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alvotech and Emergent Biosolutions

The main advantage of trading using opposite Alvotech and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.
The idea behind Alvotech and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format